文献速递急性肾损伤

儿童心脏手术后急性肾损伤预防策略:网状Meta分析

Strategies to Prevent Acute Kidney Injury after Pediatric Cardiac Surgery: A Network Meta-Analysis.
PubMed 文献 · Clin J Am Soc Nephrol · 2021-01-01

该网状Meta分析纳入20项随机对照试验共2339例患者,比较11种药物和非药物策略预防儿童心脏手术后急性肾损伤的效果。传统配对Meta分析未显示皮质激素、非诺多泮、羟乙基淀粉或远程缺血预适应较对照有显著差异;网状Meta分析未发现任何干预间显著差异;试验序贯分析提示右美托咪定可能降低80%相对风险,远程缺血预适应降低<57%相对风险。

要点

  • 多数预防策略在儿童心脏手术后AKI中未显示显著获益。
  • 右美托咪定和远程缺血预适应有有限证据提示可能有效。
  • 网状Meta分析未能证实任何干预间存在显著差异。

核心结论

  • 当前随机对照试验证据不支持大多数策略预防儿童心脏手术后急性肾损伤的有效性。
  • 仅右美托咪定和远程缺血预适应有有限证据支持。

研究设计与样本

  • 研究为网状Meta分析,检索PubMed/MEDLINE、Embase、Cochrane对照试验注册库及参考文献,截至2020年8月。
  • 纳入20项随机对照试验,共2339例患者,评估11种预防策略。

主要发现

  • 传统配对Meta分析中,皮质激素、非诺多泮、羟乙基淀粉或远程缺血预适应与对照相比无显著差异。
  • 试验序贯分析提示右美托咪定可降低80%相对风险,远程缺血预适应降低<57%相对风险。
  • 网状Meta分析未显示任何干预间(包括对乙酰氨基酚、氨茶碱、左西孟旦、米力农、常温体外循环)有显著差异。
  • 累积排序曲线下面积显示米力农(76%)最可能降低AKI风险,其次为右美托咪定(70%)、左西孟旦(70%)、氨茶碱(59%)、常温体外循环(57%)和远程缺血预适应(55%),但重叠明显。

临床怎么用

  • 现有证据不支持常规使用多数策略预防儿童心脏手术后AKI。
  • 右美托咪定和远程缺血预适应可考虑用于高风险患儿,但需更多证据验证。

局限性

  • 网状Meta分析未能显示干预间显著差异,排序概率重叠明显。
  • 部分策略证据有限,需进一步研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: AKI is a common complication after pediatric cardiac surgery and has been associated with higher morbidity and mortality. We aimed to compare the efficacy of available pharmacologic and nonpharmacologic strategies to prevent AKI after pediatric cardiac surgery. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: PubMed/MEDLINE, Embase, Cochrane Controlled Trials Register, and reference lists of relevant articles were searched for randomized controlled trials from inception until August 2020. Random effects traditional pairwise, Bayesian network meta-analyses, and trial sequential analyses were performed. RESULTS: Twenty randomized controlled trials including 2339 patients and 11 preventive strategies met the eligibility criteria. No overall significant differences were observed compared with control for corticosteroids, fenoldopam, hydroxyethyl starch, or remote ischemic preconditioning in traditional pairwise meta-analysis. In contrast, trial sequential analysis suggested a 80% relative risk reduction with dexmedetomidine and evidence of <57% relative risk reduction with remote ischemic preconditioning. Nonetheless, the network meta-analysis was unable to demonstrate any significant differences among the examined treatments, including also acetaminophen, aminophylline, levosimendan, milrinone, and normothermic cardiopulmonary bypass. Surface under the cumulative ranking curve probabilities showed that milrinone (76%) was most likely to result in the lowest risk of AKI, followed by dexmedetomidine (70%), levosimendan (70%), aminophylline (59%), normothermic cardiopulmonary bypass (57%), and remote ischemic preconditioning (55%), although all showing important overlap. CONCLUSIONS: Current evidence from randomized controlled trials does not support the efficacy of most strategies to prevent AKI in the pediatric population, apart from limited evidence for dexmedetomidine and remote ischemic preconditioning.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Van den Eynde J, Cloet N, Van Lerberghe R, et al. Strategies to Prevent Acute Kidney Injury after Pediatric Cardiac Surgery: A Network Meta-Analysis. Clin J Am Soc Nephrol. 2021. PMID: 34620647. doi:10.2215/CJN.05800421

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。